JP2024541995A5 - - Google Patents
Info
- Publication number
- JP2024541995A5 JP2024541995A5 JP2024525415A JP2024525415A JP2024541995A5 JP 2024541995 A5 JP2024541995 A5 JP 2024541995A5 JP 2024525415 A JP2024525415 A JP 2024525415A JP 2024525415 A JP2024525415 A JP 2024525415A JP 2024541995 A5 JP2024541995 A5 JP 2024541995A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- alkyl
- disease
- halogen
- structural part
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163276338P | 2021-11-05 | 2021-11-05 | |
| US63/276,338 | 2021-11-05 | ||
| PCT/US2022/079344 WO2023081854A1 (en) | 2021-11-05 | 2022-11-04 | Akt3 modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024541995A JP2024541995A (ja) | 2024-11-13 |
| JP2024541995A5 true JP2024541995A5 (enExample) | 2025-11-11 |
Family
ID=86242245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525415A Pending JP2024541995A (ja) | 2021-11-05 | 2022-11-04 | Ａｋｔ３モジュレーター |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250002511A1 (enExample) |
| EP (1) | EP4426279A4 (enExample) |
| JP (1) | JP2024541995A (enExample) |
| KR (1) | KR20240114792A (enExample) |
| CN (1) | CN118524833A (enExample) |
| AU (1) | AU2022382397A1 (enExample) |
| CA (1) | CA3236920A1 (enExample) |
| IL (1) | IL312442A (enExample) |
| MX (1) | MX2024005269A (enExample) |
| WO (1) | WO2023081854A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024251212A1 (en) * | 2023-06-06 | 2024-12-12 | Revir Therapeutics, Inc. | Isoindolinone and dihydropyrrolopridinone compounds and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005245386B2 (en) * | 2004-05-07 | 2008-11-27 | Amgen Inc. | Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |
| JP2010506856A (ja) * | 2006-10-12 | 2010-03-04 | スーパージェン， インコーポレイテッド | Ｄｎａメチル化を調整するためのキノリン誘導体 |
| US7790746B2 (en) * | 2007-10-12 | 2010-09-07 | Supergen, Inc. | Quinoline derivatives for modulating DNA methylation |
| US11291719B2 (en) * | 2016-01-15 | 2022-04-05 | Augusta University Research Institute, Inc. | Methods and compositions for modulating Akt3 |
| US10342868B2 (en) * | 2016-01-15 | 2019-07-09 | Augusta University Research Institute, Inc. | Methods and compositions for inhibiting Akt3 |
| US10292978B2 (en) * | 2016-01-15 | 2019-05-21 | Augusta University Research Institute, Inc. | Specific Akt3 inhibitor and uses thereof |
| MX2020002611A (es) * | 2017-09-07 | 2020-07-13 | Univ Res Inst Inc Augusta | Activador especifico de akt3 y usos del mismo. |
| WO2020168241A1 (en) * | 2019-02-15 | 2020-08-20 | Flagship Pioneering Inc. | X-reactivation modulators and uses thereof |
-
2022
- 2022-11-04 JP JP2024525415A patent/JP2024541995A/ja active Pending
- 2022-11-04 IL IL312442A patent/IL312442A/en unknown
- 2022-11-04 CN CN202280087319.5A patent/CN118524833A/zh active Pending
- 2022-11-04 CA CA3236920A patent/CA3236920A1/en active Pending
- 2022-11-04 US US18/707,125 patent/US20250002511A1/en active Pending
- 2022-11-04 EP EP22891119.4A patent/EP4426279A4/en active Pending
- 2022-11-04 WO PCT/US2022/079344 patent/WO2023081854A1/en not_active Ceased
- 2022-11-04 MX MX2024005269A patent/MX2024005269A/es unknown
- 2022-11-04 AU AU2022382397A patent/AU2022382397A1/en active Pending
- 2022-11-04 KR KR1020247018590A patent/KR20240114792A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2972014A1 (en) | Fused pyrimidine compounds for the treatment of hiv | |
| JP6554117B2 (ja) | 医療で使用されるインドール誘導体 | |
| CN111263767B (zh) | 作为干扰素基因调节剂的刺激剂的环状二核苷酸 | |
| US8815918B2 (en) | Imidazo [2, 1-B] [1, 3, 4] thiadiazole derivatives | |
| JP2019501133A5 (enExample) | ||
| CY1115836T1 (el) | Παραγωγα πυραζινονης και η χρηση τους στη θεραπευτικη αντιμετωπιση παθησεων των πνευμονων | |
| JP2022505835A5 (enExample) | ||
| JP2022516469A5 (enExample) | ||
| CY1119865T1 (el) | Φαρμακευτικες συνθεσεις για την αντιμετωπιση της νοσου του παρκινσον | |
| JP2013535460A5 (enExample) | ||
| CA2643177A1 (en) | Multi-cyclic compounds for treating cancer | |
| BR0316407A (pt) | Derivados de nucleosìdeo antiviral | |
| JP2016529324A5 (enExample) | ||
| BRPI0820112B8 (pt) | derivados de isoxazol-piridina, seu uso e processos de preparação e medicamento | |
| CY1113846T1 (el) | Παραγωγα πυριμιδινης για την θεραπευτικη αντιμετωπιση του ασθματος, copd, αλλεργικης ρινιτιδας, αλλεργικης επιπεφυκιτιδας, ατοπικης δερματιτιδας, καρκινου, ηπατιτιδας β, ηπατιτιδας c, hiv, hpv, βακτηριακων λοιμωξεων και δερματωσης | |
| RU2011108024A (ru) | 3-азабицикло(3.1.0) гексильные производные в качестве модуляторов метаботропных глутаматных рецепторов | |
| JP2023164918A5 (enExample) | ||
| JP2021535112A5 (enExample) | ||
| JP2024540107A5 (enExample) | ||
| JP2017520571A5 (enExample) | ||
| JP2014510147A5 (enExample) | ||
| RU2010140613A (ru) | Амиды диазабициклоалканов, селективные в отношении подтипа никотиновых ацетилхолиновых рецепторов | |
| JP2022511477A5 (enExample) | ||
| JP2025505644A5 (enExample) | ||
| JP2016525104A5 (enExample) |